Institut za onkologiju Vojvodine

Kamenitz 21204

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Hepatocellular Carcinoma

Studies at this site

• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) — Completed